arcadia

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE778.20-7.8 (-0.99 %)
PREV CLOSE ( ) 786.00
OPEN PRICE ( ) 785.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 778.20 (20)
VOLUME 5717
TODAY'S LOW / HIGH ( )774.00 790.55
52 WK LOW / HIGH ( )671.25 1061.95
NSE779.25-9.95 (-1.26 %)
PREV CLOSE( ) 789.20
OPEN PRICE ( ) 789.20
BID PRICE (QTY) 779.25 (1093)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 160849
TODAY'S LOW / HIGH( ) 774.00 792.70
52 WK LOW / HIGH ( )671.1 1050
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Andhra Pradesh-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX
NEWS
02Jul Announcement under Regulation 30 (LOD
NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug fo..
02Jul Natco Pharma launches fixed dose combi
Natco Pharma under its brand Hepcinat Plus has launched the generic fixe..
02Jul Natco Pharma informs about press relea
Natco Pharma has informed about press release titled, 'NATCO launches fi..
21Jun Appointment of Director
Inter alia, considered and approved the following : 1)The Board accepted..
21Jun Resignation of Director
Inter alia, considered and approved the following : 1)The Board accepted..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit29616982
Gross Profit 3764 8876
Operating Profit 39699678
Net Sales 729021085
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7179.55 (2.08%)
M.Cap ( in Cr)15256.04
Piramal Enterprises (BSE)
 2558.45 (1.31%)
M.Cap ( in Cr)46205.04
Astrazeneca Pharma I (BSE)
 1423.70 (1.71%)
M.Cap ( in Cr)3559.25
Pfizer (BSE)
 2571.10 (0.79%)
M.Cap ( in Cr)11762.20
Zim Laboratories (BSE)
 350.00 (4.48%)
M.Cap ( in Cr)282.09
Shareholding Pattern
PROMOTERS 48.38%
NON-INSTITUTION 20.97%
MUTUAL FUNDS/UTI 5.37%
FI/BANKS/INSURANCE 0.65%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM